Seminars in Nephrology
Volume 29, Issue 2 , Pages 97-104, March 2009

Chronic Kidney Disease/Bone and Mineral Metabolism: The Imperfect Storm

  • Mark E. Williams, MD

      Affiliations

    • Corresponding Author InformationAddress reprint requests to Mark E. Williams, MD, FACP, FASN, Associate Professor of Medicine, Harvard Medical School, Co-Director of Dialysis, Beth Israel Deaconess Medical Center, 1 Joslin Pl, Boston, MA 02215

Beth Israel Deaconess Medical Center, Boston, MA

Summary 

As kidney function declines, chronic kidney disease (CKD) becomes an increasingly systemic disorder. Most patients with CKD eventually develop subclinical or clinical abnormalities in bone and mineral metabolism. Recent observational and basic scientific studies have led to a new emphasis on the changes in phosphorus and calcium metabolism, parathyroid hormone, and vitamin D that lead to this complex systemic bone/mineral disorder (CKD/BMD). At the center of the disorder are relationships among all 4 factors that conspire to create a perfect storm, leading to secondary hyperparathyroidism (SHPT). Some key current issues that are reviewed here are as follows: (1) factors promoting SHPT, (2) the role of fibroblast growth factor-23 in CKD/BMD, (3) molecular mechanisms of SHPT, (4) mechanisms of vascular calcification, and (5) medical management of the disorder, including calcimimetics. Current therapies directed at correcting the primary abnormalities (ie, improve conditions to an imperfect storm) and minimizing the consequences of CKD/BMD are discussed.

Keywords: Kidney, mineral, hyperparathyroidism, vitamin D

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0270-9295(09)00003-5

doi:10.1016/j.semnephrol.2009.01.002

Seminars in Nephrology
Volume 29, Issue 2 , Pages 97-104, March 2009